CO4940408A1 - Composicion de aerosol farmaceutico - Google Patents

Composicion de aerosol farmaceutico

Info

Publication number
CO4940408A1
CO4940408A1 CO98033837A CO98033837A CO4940408A1 CO 4940408 A1 CO4940408 A1 CO 4940408A1 CO 98033837 A CO98033837 A CO 98033837A CO 98033837 A CO98033837 A CO 98033837A CO 4940408 A1 CO4940408 A1 CO 4940408A1
Authority
CO
Colombia
Prior art keywords
aerosol composition
pharmaceutical aerosol
inhaler
composition
aerosol
Prior art date
Application number
CO98033837A
Other languages
English (en)
Spanish (es)
Inventor
Lewis David
Meakin Brian
Paolo Ventura
Brambilla Gaetano
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940408(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of CO4940408A1 publication Critical patent/CO4940408A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO98033837A 1997-06-13 1998-06-12 Composicion de aerosol farmaceutico CO4940408A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
CO4940408A1 true CO4940408A1 (es) 2000-07-24

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98033837A CO4940408A1 (es) 1997-06-13 1998-06-12 Composicion de aerosol farmaceutico

Country Status (44)

Country Link
EP (2) EP1219293A3 (enrdf_load_html_response)
JP (1) JP4380802B2 (enrdf_load_html_response)
KR (1) KR100546239B1 (enrdf_load_html_response)
CN (1) CN1138532C (enrdf_load_html_response)
AR (1) AR012977A1 (enrdf_load_html_response)
AT (1) ATE222751T1 (enrdf_load_html_response)
AU (1) AU729966B2 (enrdf_load_html_response)
BG (1) BG63906B1 (enrdf_load_html_response)
BR (1) BR9805993B1 (enrdf_load_html_response)
CA (1) CA2263445C (enrdf_load_html_response)
CO (1) CO4940408A1 (enrdf_load_html_response)
CZ (1) CZ295521B6 (enrdf_load_html_response)
DE (1) DE69807420T3 (enrdf_load_html_response)
DK (1) DK0920302T4 (enrdf_load_html_response)
DZ (1) DZ2516A1 (enrdf_load_html_response)
EA (1) EA001259B1 (enrdf_load_html_response)
EE (1) EE03664B1 (enrdf_load_html_response)
ES (1) ES2182351T5 (enrdf_load_html_response)
GB (1) GB2326334A (enrdf_load_html_response)
GE (1) GEP20012462B (enrdf_load_html_response)
HR (1) HRP980317B1 (enrdf_load_html_response)
HU (1) HU228487B1 (enrdf_load_html_response)
ID (1) ID21491A (enrdf_load_html_response)
IL (1) IL128484A (enrdf_load_html_response)
IN (1) IN189317B (enrdf_load_html_response)
IS (1) IS2435B (enrdf_load_html_response)
IT (1) IT1293803B1 (enrdf_load_html_response)
MA (1) MA26507A1 (enrdf_load_html_response)
ME (2) MEP44008A (enrdf_load_html_response)
MY (1) MY119074A (enrdf_load_html_response)
NO (1) NO327775B1 (enrdf_load_html_response)
NZ (1) NZ334149A (enrdf_load_html_response)
PL (1) PL193721B1 (enrdf_load_html_response)
PT (1) PT920302E (enrdf_load_html_response)
RS (1) RS51274B (enrdf_load_html_response)
SA (1) SA98190821B1 (enrdf_load_html_response)
SI (1) SI0920302T2 (enrdf_load_html_response)
SK (1) SK284430B6 (enrdf_load_html_response)
TN (1) TNSN98087A1 (enrdf_load_html_response)
TR (1) TR199900288T1 (enrdf_load_html_response)
TW (1) TW555570B (enrdf_load_html_response)
UA (1) UA70289C2 (enrdf_load_html_response)
WO (1) WO1998056349A1 (enrdf_load_html_response)
ZA (1) ZA985136B (enrdf_load_html_response)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
ES2274803T3 (es) 1999-09-11 2007-06-01 Glaxo Group Limited Formulacion farmaceutica de propionato de fluticasona.
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
HUE044926T2 (hu) 2002-03-01 2019-11-28 Chiesi Farm Spa Szuperfinom formoterolkészítmény
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
JP2006516545A (ja) * 2003-02-04 2006-07-06 クリサリス テクノロジーズ インコーポレイテッド パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
NZ542957A (en) * 2003-03-20 2008-09-26 Boehringer Ingelheim Pharma Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
DK1809243T4 (da) 2004-07-02 2022-09-05 Boehringer Ingelheim Int Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
WO2009061273A1 (en) * 2007-11-07 2009-05-14 Astrazeneca Ab Dry powder formulations comprising ascorbic acid derivates
CN103079619B (zh) * 2010-09-06 2017-03-01 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
EP3610877A1 (en) * 2016-09-19 2020-02-19 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503304A (ja) † 1986-03-10 1988-12-02 ブルグハルト，クルト 医薬製剤およびその製造方法
EP0259383B1 (de) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Pharmazeutikum sowie verfahren zu seiner herstellung
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
ES2064160T3 (es) † 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
HUT67449A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane
US6503482B1 (en) † 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
WO1993011745A1 (en) * 1991-12-12 1993-06-24 Glaxo Group Limited Medicaments
EP0617610B1 (en) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB2288978B (en) * 1992-12-09 1997-04-09 Boehringer Ingelheim Pharma Hydrocarbon inhalant solutions stabilised by organic or inorganic acids
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
DE69523301T2 (de) † 1994-05-13 2002-07-04 Aradigm Corp., Hayward Ein narkotikum enthaltende aerosolformulierung
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
ATE301991T1 (de) † 1996-12-04 2005-09-15 Link Products Ltd Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung
ES2178817T3 (es) † 1997-02-05 2003-01-01 Jago Res Ag Formulaciones medicinales de aerosol.

Also Published As

Publication number Publication date
CA2263445A1 (en) 1998-12-17
HRP980317A2 (en) 1999-04-30
ID21491A (id) 1999-06-17
UA70289C2 (uk) 2004-10-15
JP4380802B2 (ja) 2009-12-09
RS51274B (sr) 2010-12-31
ES2182351T3 (es) 2003-03-01
PL331531A1 (en) 1999-07-19
HUP0001339A3 (en) 2000-10-30
SI0920302T1 (en) 2002-12-31
AU8626298A (en) 1998-12-30
SK284430B6 (sk) 2005-04-01
ES2182351T5 (es) 2007-03-16
EP0920302B1 (en) 2002-08-28
NO327775B1 (no) 2009-09-21
IS2435B (is) 2008-10-15
EE9900055A (et) 1999-08-16
BG103221A (en) 1999-09-30
BG63906B1 (bg) 2003-06-30
GEP20012462B (en) 2001-06-25
EP1219293A2 (en) 2002-07-03
YU6999A (sh) 2000-03-21
HUP0001339A2 (hu) 2000-09-28
PT920302E (pt) 2002-11-29
HK1022271A1 (en) 2000-08-04
MA26507A1 (fr) 2004-12-20
IN189317B (enrdf_load_html_response) 2003-02-08
NZ334149A (en) 2000-07-28
EP0920302B2 (en) 2006-06-21
HRP980317B1 (en) 2002-06-30
TNSN98087A1 (fr) 2005-03-15
SI0920302T2 (sl) 2006-10-31
WO1998056349A1 (en) 1998-12-17
MEP44008A (en) 2011-02-10
CA2263445C (en) 2008-09-09
EP1219293A3 (en) 2003-05-28
SK17699A3 (en) 1999-07-12
KR100546239B1 (ko) 2006-01-26
DE69807420T3 (de) 2006-11-16
TW555570B (en) 2003-10-01
NO990594L (no) 1999-04-13
HU228487B1 (en) 2013-03-28
DK0920302T4 (da) 2006-10-09
EA199900201A1 (ru) 1999-06-24
MY119074A (en) 2005-03-31
GB2326334A (en) 1998-12-23
DK0920302T3 (da) 2002-12-23
EA001259B1 (ru) 2000-12-25
KR20000068171A (ko) 2000-11-25
IS4974A (is) 1999-02-11
ME00333B (me) 2011-02-10
ZA985136B (en) 1999-01-07
JP2000516965A (ja) 2000-12-19
IL128484A (en) 2004-09-27
DE69807420T2 (de) 2003-05-08
CZ295521B6 (cs) 2005-08-17
CN1229355A (zh) 1999-09-22
DZ2516A1 (fr) 2004-11-08
ITMI971798A1 (it) 1999-01-28
ATE222751T1 (de) 2002-09-15
IL128484A0 (en) 2000-01-31
AU729966B2 (en) 2001-02-15
EE03664B1 (et) 2002-04-15
AR012977A1 (es) 2000-11-22
IT1293803B1 (it) 1999-03-10
GB9712434D0 (en) 1997-08-13
NO990594D0 (no) 1999-02-09
BR9805993B1 (pt) 2009-05-05
BR9805993A (pt) 1999-08-31
DE69807420D1 (de) 2002-10-02
SA98190821B1 (ar) 2006-11-19
EP0920302A1 (en) 1999-06-09
CZ46299A3 (cs) 1999-07-14
CN1138532C (zh) 2004-02-18
TR199900288T1 (xx) 1999-09-21
PL193721B1 (pl) 2007-03-30

Similar Documents

Publication Publication Date Title
CO4940408A1 (es) Composicion de aerosol farmaceutico
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
AR029523A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
NO990454L (no) Aerosol-materiale
MX9704550A (es) Formulaciones de medicamentos en aerosol.
DK0616525T3 (da) Medikamenter
NO20012517L (no) Farmasöytisk aerosolsammensetning inneholdende HFA 227 og HFA
ES2193186T3 (es) Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc.
ES2126536A1 (es) "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion.
TNSN04148A1 (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
BR0107730A (pt) Inalador aerosol
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
ATE381339T1 (de) Aerosol-formulierungen mit estern von 3,17- dihydroxyöstratrien-derivaten zur pulmonalen abgabe